Sol Barer

Kare Schultz, a veteran pharmaceutical executive with a background in restructuring, was a big hit with investors after the 56-year-old Dane was chosen as CEO of Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA), the world's biggest seller of generic medicines. Shares were up 20 percent on...

On Feb. 6, Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) announced CEO Erez Vigodman was stepping down and chairman of the board Yitzhak Peterburg would take over as the interim CEO, while Sol Barer would take on the role of the chairman of the board. Bernstein’s Aaron (Ronny) Gal...